SecBot SecBot
SECBOTREPLAY Home › Report › QTTB

QTTB · Q32 Bio Inc

Q32 Bio Inc. · 8-K filed Apr 24, 2026 at 16:09 ET

At the news

BEARISHIMPACT 6/10

8-K filed Apr 24, 2026 at 16:09 ET

Q32 Bio Inc. has filed an additional prospectus supplement to raise up to $75 million through its at-the-market (ATM) offering program with Cantor Fitzgerald, following the full utilization of a prior $14.2 million ATM offering. This new shelf capacity provides continued access to equity funding for the clinical-stage biotech.

  • Q32 Bio has fully drawn down a prior $14.2 million ATM offering with Cantor Fitzgerald
  • Filed a new prospectus supplement to offer up to $75 million in common stock via the same ATM program
  • The offering is under a shelf registration (Form S-3) declared effective April 21, 2025
  • No specific use of proceeds or pricing details disclosed in this filing

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access